펄스 바이오사이언시스, Inc.
US ˙ NasdaqCM ˙ US74587B1017

SecurityPLSE / Pulse Biosciences, Inc.
InstitutionUBS Group AG
Latest Disclosed Ownership33,954 shares
Latest Disclosed Value $ 733,066
UBS Group AG ownership in PLSE / Pulse Biosciences, Inc.

On May 5, 2026 - UBS Group AG filed a 13F-HR form disclosing ownership of 33,954 shares of Pulse Biosciences, Inc. (US:PLSE) valued at $733,067 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 29, 2026 disclosing 75,909 shares of Pulse Biosciences, Inc.. This represents a change in shares of -55.27% during the quarter. The current value of the position is $914,721 USD.

UBS Group AG has a history of taking positions in derivatives of the underlying security (PLSE) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

PLSE / Pulse Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F PULSE BIOSCIENCES COM 74587B101 33,954 -41,955 -55.27 733 -29.65 0.0000
2026-01-29 2025-12-31 13F PULSE BIOSCIENCES COM 74587B101 75,909 -947 -1.23 1,042 -23.38 0.0000
2025-11-13 2025-09-30 13F PULSE BIOSCIENCES COM 74587B101 76,856 26,739 53.35 1,360 79.89 0.0002
2025-08-14 2025-06-30 13F PULSE BIOSCIENCES COM 74587B101 50,117 -4,615 -8.43 756 -14.09 0.0001
2025-05-13 2025-03-31 13F PULSE BIOSCIENCES COM 74587B101 54,732 27,194 98.75 881 83.72 0.0002
2025-02-14 2024-12-31 13F PULSE BIOSCIENCES COM 74587B101 27,538 14,746 115.28 479 113.84 0.0001
2024-11-14 2024-09-30 13F PULSE BIOSCIENCES COM 74587B101 12,792 7,222 129.66 224 261.29 0.0000
2024-08-14 2024-06-30 13F PULSE BIOSCIENCES COM 74587B101 5,570 -10,628 -65.61 62 -56.03 0.0000
2024-05-13 2024-03-31 13F PULSE BIOSCIENCES COM 74587B101 16,198 -2,463 -13.20 141 -38.16 0.0000
2024-02-09 2023-12-31 13F PULSE BIOSCIENCES COM 74587B101 18,661 9,632 106.68 228 533.33 0.0001
2023-11-09 2023-09-30 13F PULSE BIOSCIENCES COM 74587B101 9,029 -353 -3.76 36 -46.27 0.0000
2023-08-11 2023-06-30 13F PULSE BIOSCIENCES COM 74587B101 9,382 9,382 67 0.0000
2023-02-08 2022-12-31 13F PULSE BIOSCIENCES COM 74587B101 0 -100 -100.00 0 0.0000
2022-11-10 2022-09-30 13F PULSE BIOSCIENCES COM 74587B101 100 -703 -87.55 0 -100.00
2022-08-10 2022-06-30 13F PULSE BIOSCIENCES COM 74587B101 803 480 148.61 1 -50.00 0.0000
2022-05-16 2022-03-31 13F PULSE BIOSCIENCES COM 74587B101 323 -6,471 -95.25 2 -98.02 0.0000
2022-02-14 2021-12-31 13F PULSE BIOSCIENCES COM 74587B101 6,794 6,794 101 0.0000
2021-08-13 2021-06-30 13F PULSE BIOSCIENCES COM 74587B101 0 -3,264 -100.00 0 -100.00
2021-05-12 2021-03-31 13F PULSE BIOSCIENCES COM 74587B101 3,264 -3,899 -54.43 77 -54.97 0.0000
2021-02-11 2020-12-31 13F PULSE BIOSCIENCES COM 74587B101 7,163 -1,272 -15.08 171 72.73 0.0001
2020-11-12 2020-09-30 13F PULSE BIOSCIENCES COM 74587B101 8,435 -4,265 -33.58 99 -25.56 0.0000
2020-07-31 2020-06-30 13F PULSE BIOSCIENCES COM 74587B101 12,700 -2,589 -16.93 133 22.02 0.0001
2020-05-01 2020-03-31 13F PULSE BIOSCIENCES COM 74587B101 15,289 415 2.79 109 -45.23 0.0001
2020-02-14 2019-12-31 13F PULSE BIOSCIENCES COM 74587B101 14,874 1,583 11.91 199 -2.93 0.0001
2019-11-14 2019-09-30 13F PULSE BIOSCIENCES COM 74587B101 13,291 5,723 75.62 205 105.00 0.0001
2019-08-14 2019-06-30 13F PULSE BIOSCIENCES COM 74587B101 7,568 -2,861 -27.43 100 -45.36 0.0000
2019-05-14 2019-03-31 13F PULSE BIOSCIENCES COM 74587B101 10,429 -2,720 -20.69 183 21.19 0.0001
2019-02-14 2018-12-31 13F PULSE BIOSCIENCES COM 74587B101 13,149 -4,565 -25.77 151 -39.84 0.0001
2018-11-14 2018-09-30 13F PULSE BIOSCIENCES COM 74587B101 17,714 986 5.89 251 -0.79 0.0001
2018-08-14 2018-06-30 13F PULSE BIOSCIENCES COM 74587B101 16,728 7,914 89.79 253 112.61 0.0001
2018-05-15 2018-03-31 13F PULSE BIOSCIENCES COM 74587B101 8,814 -14 -0.16 119 -42.79 0.0001
2018-02-14 2017-12-31 13F PULSE BIOSCIENCES COM 74587B101 8,828 -3,598 -28.96 208 -9.96 0.0001
2017-11-14 2017-09-30 13F PULSE BIOSCIENCES COM 74587B101 12,426 3,199 34.67 231 -27.59 0.0001
2017-11-14 2017-06-30 13F/A-1 PULSE BIOSCIENCES COM 74587B101 9,227 -16,559 -64.22 319 -39.35 0.0002
2017-08-14 2017-06-30 13F PULSE BIOSCIENCES COM 74587B101 9,227 -16,559 319
2017-11-14 2017-03-31 13F/A-1 PULSE BIOSCIENCES COM 74587B101 25,786 -10,064 -28.07 526 125.75 0.0003
2017-05-12 2017-03-31 13F PULSE BIOSCIENCES COM 74587B101 25,786 -10,064 526
2017-02-14 2016-12-31 13F PULSE BIOSCIENCES COM 74587B101 35,850 4,511 14.39 233 18.27 0.0001
2016-11-14 2016-09-30 13F PULSE BIOSCIENCES COM 74587B101 31,339 3,344 11.94 197 56.35 0.0001
2016-08-12 2016-06-30 13F PULSE BIOSCIENCES COM 74587B101 27,995 27,995 126 0.0001
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2025-05-13 2025-03-31 13F PULSE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2025-02-14 2024-12-31 13F PULSE BIOSCIENCES COM Call 3,800 -72.46 66 -72.73 n/a n/a n/a
2024-11-14 2024-09-30 13F PULSE BIOSCIENCES COM Call 13,800 242 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.